IFIH1 and interstitial lung disease: RP-ILD has an extremely high mortality rate, which is perhaps as high as 59.5% at 3 months [3], and is the leading cause of death in anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive DM.